Co-Authors
This is a "connection" page, showing publications co-authored by Cezmi Akdis and Milena Sokolowska.
Connection Strength
2.421
-
Highlights in immune response, microbiome and precision medicine in allergic disease and asthma. Curr Opin Immunol. 2017 Oct; 48:iv-ix.
Score: 0.736
-
Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021 02; 76(2):428-455.
Score: 0.229
-
Advances and recent developments in asthma in 2020. Allergy. 2020 12; 75(12):3124-3146.
Score: 0.227
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020 10; 75(10):2445-2476.
Score: 0.226
-
A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020 10; 75(10):2503-2541.
Score: 0.223
-
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020 07; 75(7):1564-1581.
Score: 0.223
-
Gene expression signatures of circulating human type 1, 2, and 3 innate lymphoid cells. J Allergy Clin Immunol. 2019 06; 143(6):2321-2325.
Score: 0.203
-
Microbiome and asthma. Asthma Res Pract. 2018; 4:1.
Score: 0.187
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy. 2021 10; 76(10):2952-2964.
Score: 0.061
-
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives. Allergy. 2021 06; 76(6):1640-1660.
Score: 0.059
-
Ozone exposure induces respiratory barrier biphasic injury and inflammation controlled by IL-33. J Allergy Clin Immunol. 2018 09; 142(3):942-958.
Score: 0.047